Get started
Author

Thomas Langenickel

Institution: Ethris (Germany)
Observed institution: Ethris (Germany)
ORCID: 0009-0000-6891-1968
Observed ORCID: 0009-0000-6891-1968
OpenAlex ID: A5105098610
Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice
2024 · Anna Macht, Yiqi Huang, et al. · EMBO Reports · 9
PDF
ETH47 is a novel mRNA drug candidate for the prevention of asthma exacerbations
2025 · Thomas Langenickel, Nigel Tomkinson, et al. · European Respiratory Journal · 2
mRNA therapy improves the composition and motility in CCDC40- deficient cilia in vitro and in vivo
2026 · Kai Wohlgemuth, Margarida Rasteiro, et al. · American Journal of Respiratory Cell and Molecular Biology · 1
Mucosal INFλ mRNA-based immunomodulation with ETH47 confers antiviral protection from influenza A and SARS-CoV-2 in vitro and in vivo
2025 · Thomas Langenickel, Anna Macht, et al. · European Respiratory Journal
Works count: 4
Citation count: 12
H-index: 2
I10-index:
Year
Topic
Type